113 related articles for article (PubMed ID: 29788737)
21. Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Abe M; Watanabe K; Shinozaki-Ushiku A; Ushiku T; Abe T; Fujihara Y; Amano Y; Zong L; Wang CP; Kubo E; Inaki R; Kinoshita N; Yamashita S; Takai D; Ushijima T; Nagase T; Hoshi K
BMC Cancer; 2019 Jan; 19(1):52. PubMed ID: 30634950
[TBL] [Abstract][Full Text] [Related]
22. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
Horlings HM; van Laar RK; Kerst JM; Helgason HH; Wesseling J; van der Hoeven JJ; Warmoes MO; Floore A; Witteveen A; Lahti-Domenici J; Glas AM; Van't Veer LJ; de Jong D
J Clin Oncol; 2008 Sep; 26(27):4435-41. PubMed ID: 18802156
[TBL] [Abstract][Full Text] [Related]
24. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
25. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
[TBL] [Abstract][Full Text] [Related]
26. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
27. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
Kermanshahi TR; Jayachandran P; Chang DT; Pai R
Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
[TBL] [Abstract][Full Text] [Related]
28. Update on the diagnosis of cancer of unknown primary (CUP) origin.
Ariza A; Balañá C; Concha Á; Hitt R; Homet B; Matilla A; Alba E
Clin Transl Oncol; 2011 Jul; 13(7):434-41. PubMed ID: 21775269
[TBL] [Abstract][Full Text] [Related]
29. [Space-occupying lesions in the liver: incidence of adenocarcinoma metastases of unknown primary site].
Eickhoff A; Spiethoff A; Hartmann D; Jakobs R; Weickert U; Schilling D; Eickhoff JC; Bohrer MH; Riemann JF
Dtsch Med Wochenschr; 2007 Feb; 132(8):369-74. PubMed ID: 17299675
[TBL] [Abstract][Full Text] [Related]
30. Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.
El-Zammar OA; Zhang S; Katzenstein AL
Diagn Mol Pathol; 2009 Sep; 18(3):133-7. PubMed ID: 19704257
[TBL] [Abstract][Full Text] [Related]
31. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
Varadhachary GR; Spector Y; Abbruzzese JL; Rosenwald S; Wang H; Aharonov R; Carlson HR; Cohen D; Karanth S; Macinskas J; Lenzi R; Chajut A; Edmonston TB; Raber MN
Clin Cancer Res; 2011 Jun; 17(12):4063-70. PubMed ID: 21531815
[TBL] [Abstract][Full Text] [Related]
32. Dual surrogate markers for rapid prediction of epidermal growth factor receptor mutation status in advanced adenocarcinoma of the lung: A novel approach in resource-limited setting.
Udupa KS; Rajendranath R; Sagar TG; Sundersingh S; Joseph T
Indian J Cancer; 2015; 52(3):266-8. PubMed ID: 26905105
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 germline mutation presenting as an adenocarcinoma of unknown primary.
Klein P; Prolla G; Wallach R; Melamed J; Muggia FM
Cancer J; 2000; 6(3):188-90. PubMed ID: 10882335
[TBL] [Abstract][Full Text] [Related]
34. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.
Matthew EM; Zhou L; Yang Z; Dicker DT; Holder SL; Lim B; Harouaka R; Zheng SY; Drabick JJ; Lamparella NE; Truica CI; El-Deiry WS
Oncotarget; 2016 Jan; 7(4):3662-76. PubMed ID: 26695546
[TBL] [Abstract][Full Text] [Related]
35. New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling.
Varadhachary G
Clin Cancer Res; 2013 Aug; 19(15):4027-33. PubMed ID: 23519898
[TBL] [Abstract][Full Text] [Related]
36. [Progress in the diagnosis of unknown primary neoplasms].
Nicolosi A; Massidda B; Rais M; Addis E; Tarquini A
Minerva Chir; 1990 Nov; 45(21-22):1343-6. PubMed ID: 2097558
[TBL] [Abstract][Full Text] [Related]
37. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
38. [Peritoneal carcinomatosis of unknown origin].
Marchal N; Gennigens C; Jerusalem G
Rev Med Liege; 2012 Nov; 67(11):582-6. PubMed ID: 23346828
[TBL] [Abstract][Full Text] [Related]
39. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis.
Park SJ; Sun JY; Hong K; Kwak JY; Kim EK; Chung WY; Choi JR
Clin Chem Lab Med; 2013 Aug; 51(8):1673-80. PubMed ID: 23585181
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of carcinoma of unknown primary in the head and neck.
Issing WJ; Taleban B; Tauber S
Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):436-43. PubMed ID: 12684829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]